Nova Patents
LU92137I2

Untitled record

Abstract

The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines (I) and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

Term

6.3 yearsto projected expiry

Projected expiry 18 January 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

231 members in 37 offices

This recordMember, by publication datePriority claim27 more offices are in the list below

Priority claims6

Priority claims
DocumentOfficeKindDate
74990505United States of AmericaP
81023106United States of AmericaP
85062506United States of AmericaP
85687206United States of AmericaP
85940406United States of AmericaP
2006047369United States of AmericaW

Members231

Family members, oldest first
DocumentOfficeKind
US2007135461A1United States of AmericaA1
AU2006326548A1AustraliaA1
CA2632466A1CanadaA1
WO2007070514A1World Intellectual Property Organization (WIPO)A1
TW200728275ATaiwan Province of ChinaA
AR057995A1ArgentinaA1
CR10065ACosta RicaA
ECSP088540AEcuadorA
KR20080079677ARepublic of KoreaA
EP1966202A1European Patent Office (EPO)A1
IL192019A0IsraelA0
IL192019D0IsraelD0
EA200870048A1Eurasian Patent Organization (EAPO)A1
JP2009519340AJapanA
CN101448826AChinaA
US2009181959A1United States of AmericaA1
HK1124840AHong Kong, ChinaA
HK1124840A1Hong Kong, ChinaA1
US7598257B2United States of AmericaB2
US2010022522A1United States of AmericaA1
NZ569015ANew ZealandA
EP2343298A1European Patent Office (EPO)A1
EP2343299A1European Patent Office (EPO)A1
EP2348023A1European Patent Office (EPO)A1
US2011223210A1United States of AmericaA1
US2011224157A1United States of AmericaA1
EP1966202B1European Patent Office (EPO)B1
AT525374TAustriaT
ATE525374T1AustriaT1
BRPI0619817A2BrazilA2
JP2011252024AJapanA
KR20110137406ARepublic of KoreaA
PT1966202EPortugalE
DK1966202T3DenmarkT3
HRP20110903T1CroatiaT1
SI1966202T1SloveniaT1
ES2373688T3SpainT3
PL1966202T3PolandT3
EP2426129A1European Patent Office (EPO)A1
AU2006326548B2AustraliaB2
SG179430A1SingaporeA1
ECSP12008540AEcuadorA
EP2455382A1European Patent Office (EPO)A1
UA98449C2UkraineC2
ZA200805165BSouth AfricaB
RS52101BSerbiaB
EP2474545A1European Patent Office (EPO)A1
HK1160111A1Hong Kong, ChinaA1
HK1160115A1Hong Kong, ChinaA1
HK1160137A1Hong Kong, ChinaA1
JP5017278B2JapanB2
TW201240663ATaiwan Province of ChinaA
KR20120120462ARepublic of KoreaA
KR20120120463ARepublic of KoreaA
HK1168090A1Hong Kong, ChinaA1
KR101216055B1Republic of KoreaB1
FR13C0007I1FranceI1
KR101218214B1Republic of KoreaB1
LTPA2013002I1LithuaniaI1
HK1171023A1Hong Kong, ChinaA1
US8415362B2United States of AmericaB2
US2013137681A1United States of AmericaA1
CN103214483AChinaA
CN103214484AChinaA
CN103254190AChinaA
US8530485B2United States of AmericaB2
CA2632466CCanadaC
US8541425B2United States of AmericaB2
TWI410407BTaiwan Province of ChinaB
CR20130506ACosta RicaA
KR101324737B1Republic of KoreaB1
ME01312BMontenegroB
US2014005210A1United States of AmericaA1
US2014018374A1United States of AmericaA1
LU92137I2This recordLuxembourgI2
FR13C0007I2FranceI2
JP2014051531AJapanA
EA019504B1Eurasian Patent Organization (EAPO)B1
IL192019AIsraelA
KR101391900B1Republic of KoreaB1
IL231992A0IsraelA0
IL231992D0IsraelD0
US2014243360A1United States of AmericaA1
TW201434835ATaiwan Province of ChinaA
CN103214483BChinaB
TWI468162BTaiwan Province of ChinaB
US8933086B2United States of AmericaB2
US8946245B2United States of AmericaB2
JP5710430B2JapanB2
EP2343298B1European Patent Office (EPO)B1
EP2348023B1European Patent Office (EPO)B1
TW201522344ATaiwan Province of ChinaA
DK2348023T3DenmarkT3
US9079912B2United States of AmericaB2
ES2543903T3SpainT3
ES2543904T3SpainT3
US2015238492A1United States of AmericaA1
HRP20150837T1CroatiaT1
PT2348023EPortugalE
CY1112762T1CyprusT1
Showing 100 of 231